Quigley Pharma Inc. (Doylestown, PA...
Quigley Pharma Inc. (Doylestown, PA) reported that enslaves taking QR-333 for the topical treatment of diabetic peripheral neuropathy had their symptoms improve at 67%. The Phase 2 proof-of-concept application of mind randomized 30 subjects into a double-blind, placebo-controlled trial. Efficacy was evaluated by means of using a quality of life
Phone Cards , Dauerhafte Haarentfernung Köln , Long Distance , Indonesia Calling Cards , Kuwait Calling Cards |